Male/female adults
Conditions
Sponsors
CPCC Company Limited
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Men and women aged 20 to below 35 years at the time of consent acquisition. 2. Subjects with a Body Mass Index (BMI) less than 30.0 kg/m2. 3. Non-smokers (no smoking in the past year). 4. Subjects who can give informed consent to partake in this study, after being provided with an explanation of the protocol detail.
Exclusion criteria
Exclusion criteria: 1. Subjects unable to adhere to the trial protocol during the study period. 2. Subjects consuming Food for Specified Health Uses (FOSHU), Foods with Function Claims, or health supplements (including supplements) that affect the autonomic nervous system, metabolism, and sleep, and cannot discontinue use during the study period. 3. Subjects taking medications or quasi-drugs that affect the autonomic nervous system, metabolism, and sleep, and cannot discontinue use during the study period. 4. Subjects who are participating in the other clinical trials and/or who have participated in the other clinical trials within 4 weeks prior to the current trial and/or who are planning to participate in the other clinical trials at the time of consent acquisition. 5. Subjects who have experienced significant life changes such as moving, changing jobs, or separation from close relatives within the last three months prior to consent acquisition, which could lead to high stress, or those likely to experience such events during the study period. 6. Subjects with irregular life rhythms (including those with highly irregular meal times, shift workers, night workers, etc.). 7. Subjects who engage in excessive physical exercise routinely. 8. Subjects with excessive alcohol intake. 9. Subjects with severe symptoms of Premenstrual Syndrome (PMS). 10. Subjects with a current or past history of drug or alcohol dependence. 11. Subjects with allergic rhinitis that may interfere with trial operations. 12. Subjects under medical supervision for dietary or exercise therapy. 13. Subjects currently receiving treatment for, or with a history of, mental disorders (such as depression) or sleep disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Psychological Questionnaire | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart Rate | — |
Countries
Japan
Contacts
Public ContactMasanori Numa
CPCC Company Limited Clinical Planning Department
Outcome results
None listed